GSK, a leading multinational pharmaceutical and biotechnology company, consistently seeks innovative solutions to develop new vaccines and specialty medicines efficiently and with top quality. In pursuit of this goal, they sought a solution to address pH variability in bioreactors, aiming to mitigate risks to product batches and reduce process drift and equipment failures.